Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 913 to 924 of 937 entries
Sorted by: Best Match Show Resources per page
Impact of extensive negative pressure wound therapy on neonatal respiration: A case report.

Clinical case reports

Osawa I, Tsuboi N, Nosaka N, Nishimura N, Nakagawa S.
PMID: 34721866
Clin Case Rep. 2021 Oct 25;9(10):e05008. doi: 10.1002/ccr3.5008. eCollection 2021 Oct.

An extensive topical negative pressure wound therapy (NPWT) from the abdominal to chest walls in neonates may decrease the compliance of the chest wall. Therefore, it is important to monitor respiratory function carefully during the procedure.

Cite
Osawa I, Tsuboi N, Nosaka N, et al. Impact of extensive negative pressure wound therapy on neonatal respiration: A case report. Clin Case Rep. 2021;9(10):e05008doi: 10.1002/ccr3.5008.
Osawa, I., Tsuboi, N., Nosaka, N., Nishimura, N., & Nakagawa, S. (2021). Impact of extensive negative pressure wound therapy on neonatal respiration: A case report. Clinical case reports, 9(10), e05008. https://doi.org/10.1002/ccr3.5008
Osawa, Ichiro, et al. "Impact of extensive negative pressure wound therapy on neonatal respiration: A case report." Clinical case reports vol. 9,10 (2021): e05008. doi: https://doi.org/10.1002/ccr3.5008
Osawa I, Tsuboi N, Nosaka N, Nishimura N, Nakagawa S. Impact of extensive negative pressure wound therapy on neonatal respiration: A case report. Clin Case Rep. 2021 Oct 25;9(10):e05008. doi: 10.1002/ccr3.5008. eCollection 2021 Oct. PMID: 34721866; PMCID: PMC8543050.
Copy Download .nbib Format: NLM
Role of Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Diagnosis of Pancreatic Cancer.

Diagnostics (Basel, Switzerland)

Ishii Y, Serikawa M, Tsuboi T, Kawamura R, Tsushima K, Nakamura S, Hirano T, Fukiage A, Mori T, Ikemoto J, Kiyoshita Y, Saeki S, Tamura Y, Miyamoto S, Chayama K.
PMID: 33557084
Diagnostics (Basel). 2021 Feb 04;11(2). doi: 10.3390/diagnostics11020238.

Pancreatic cancer has the poorest prognosis among all cancers, and early diagnosis is essential for improving the prognosis. Along with radiologic modalities, such as computed tomography (CT) and magnetic resonance imaging (MRI), endoscopic modalities play an important role in...

Cite
Ishii Y, Serikawa M, Tsuboi T, et al. Role of Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Diagnosis of Pancreatic Cancer. Diagnostics (Basel). 2021;11(2)doi: 10.3390/diagnostics11020238.
Ishii, Y., Serikawa, M., Tsuboi, T., Kawamura, R., Tsushima, K., Nakamura, S., Hirano, T., Fukiage, A., Mori, T., Ikemoto, J., Kiyoshita, Y., Saeki, S., Tamura, Y., Miyamoto, S., & Chayama, K. (2021). Role of Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Diagnosis of Pancreatic Cancer. Diagnostics (Basel, Switzerland), 11(2), . https://doi.org/10.3390/diagnostics11020238
Ishii, Yasutaka, et al. "Role of Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Diagnosis of Pancreatic Cancer." Diagnostics (Basel, Switzerland) vol. 11,2 (2021). doi: https://doi.org/10.3390/diagnostics11020238
Ishii Y, Serikawa M, Tsuboi T, Kawamura R, Tsushima K, Nakamura S, Hirano T, Fukiage A, Mori T, Ikemoto J, Kiyoshita Y, Saeki S, Tamura Y, Miyamoto S, Chayama K. Role of Endoscopic Ultrasonography and Endoscopic Retrograde Cholangiopancreatography in the Diagnosis of Pancreatic Cancer. Diagnostics (Basel). 2021 Feb 04;11(2). doi: 10.3390/diagnostics11020238. PMID: 33557084; PMCID: PMC7913831.
Copy Download .nbib Format: NLM
Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.

Expert review of anticancer therapy

Suzuki J, Tsuboi M, Ishii G.
PMID: 34904919
Expert Rev Anticancer Ther. 2022 Jan 02;1-14. doi: 10.1080/14737140.2022.2019018. Epub 2022 Jan 02.

INTRODUCTION: Non-small cell lung cancer (NSCLC) has a markedly poor prognosis as it progresses, and the prognosis is still unsatisfactory even with modern treatments. Cancer is composed of not only cancer cells, but also stroma consisting of various cell...

Cite
Suzuki J, Tsuboi M, Ishii G. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer. Expert Rev Anticancer Ther. 2022;1-14doi: 10.1080/14737140.2022.2019018.
Suzuki, J., Tsuboi, M., & Ishii, G. (2022). Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer. Expert review of anticancer therapy, 1-14. https://doi.org/10.1080/14737140.2022.2019018
Suzuki, Jun, et al. "Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer." Expert review of anticancer therapy vol. (2022): 1-14. doi: https://doi.org/10.1080/14737140.2022.2019018
Suzuki J, Tsuboi M, Ishii G. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer. Expert Rev Anticancer Ther. 2022 Jan 02;1-14. doi: 10.1080/14737140.2022.2019018. Epub 2022 Jan 02. PMID: 34904919.
Copy Download .nbib Format: NLM
Dysregulated Immune Responses by ASK1 Deficiency Alter Epithelial Progenitor Cell Fate and Accelerate Metaplasia Development during .

Microorganisms

Hayakawa Y, Hirata Y, Hata M, Tsuboi M, Oya Y, Kurokawa K, Abe S, Arai J, Suzuki N, Nakagawa H, Fujiwara H, Tateishi K, Maeda S, Koike K.
PMID: 33542169
Microorganisms. 2020 Dec 14;8(12). doi: 10.3390/microorganisms8121995.

The mechanism of

Cite
Hayakawa Y, Hirata Y, Hata M, et al. Dysregulated Immune Responses by ASK1 Deficiency Alter Epithelial Progenitor Cell Fate and Accelerate Metaplasia Development during . Microorganisms. 2020;8(12)doi: 10.3390/microorganisms8121995.
Hayakawa, Y., Hirata, Y., Hata, M., Tsuboi, M., Oya, Y., Kurokawa, K., Abe, S., Arai, J., Suzuki, N., Nakagawa, H., Fujiwara, H., Tateishi, K., Maeda, S., & Koike, K. (2020). Dysregulated Immune Responses by ASK1 Deficiency Alter Epithelial Progenitor Cell Fate and Accelerate Metaplasia Development during . Microorganisms, 8(12), . https://doi.org/10.3390/microorganisms8121995
Hayakawa, Yoku, et al. "Dysregulated Immune Responses by ASK1 Deficiency Alter Epithelial Progenitor Cell Fate and Accelerate Metaplasia Development during ." Microorganisms vol. 8,12 (2020). doi: https://doi.org/10.3390/microorganisms8121995
Hayakawa Y, Hirata Y, Hata M, Tsuboi M, Oya Y, Kurokawa K, Abe S, Arai J, Suzuki N, Nakagawa H, Fujiwara H, Tateishi K, Maeda S, Koike K. Dysregulated Immune Responses by ASK1 Deficiency Alter Epithelial Progenitor Cell Fate and Accelerate Metaplasia Development during . Microorganisms. 2020 Dec 14;8(12). doi: 10.3390/microorganisms8121995. PMID: 33542169; PMCID: PMC7765114.
Copy Download .nbib Format: NLM
Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia.

ERJ open research

Sugino K, Ono H, Shimizu H, Kurosawa T, Matsumoto K, Ando M, Mori K, Tsuboi E, Homma S, Kishi K.
PMID: 33681342
ERJ Open Res. 2021 Mar 01;7(1). doi: 10.1183/23120541.00196-2020. eCollection 2021 Jan.

BACKGROUND: There are no established therapeutic options available for idiopathic pleuroparenchymal fibroelastosis (IPPFE) apart from supportive care and lung transplantation. Furthermore, it is known that IPPFE with a usual interstitial pneumonia (UIP) pattern and lower lobe predominance is a...

Cite
Sugino K, Ono H, Shimizu H, et al. Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia. ERJ Open Res. 2021;7(1)doi: 10.1183/23120541.00196-2020.
Sugino, K., Ono, H., Shimizu, H., Kurosawa, T., Matsumoto, K., Ando, M., Mori, K., Tsuboi, E., Homma, S., & Kishi, K. (2021). Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia. ERJ open research, 7(1), . https://doi.org/10.1183/23120541.00196-2020
Sugino, Keishi, et al. "Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia." ERJ open research vol. 7,1 (2021). doi: https://doi.org/10.1183/23120541.00196-2020
Sugino K, Ono H, Shimizu H, Kurosawa T, Matsumoto K, Ando M, Mori K, Tsuboi E, Homma S, Kishi K. Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia. ERJ Open Res. 2021 Mar 01;7(1). doi: 10.1183/23120541.00196-2020. eCollection 2021 Jan. PMID: 33681342; PMCID: PMC7917230.
Copy Download .nbib Format: NLM
Pathologic Diabetic Nephropathy in Autopsied Diabetic Cases With Normoalbuminuria From a Japanese Community-Based Study.

Kidney international reports

Sasaki T, Nakagawa K, Hata J, Hirakawa Y, Shibata M, Nakano T, Tsuboi N, Oda Y, Kitazono T, Yokoo T, Ninomiya T.
PMID: 34901572
Kidney Int Rep. 2021 Sep 22;6(12):3035-3044. doi: 10.1016/j.ekir.2021.09.007. eCollection 2021 Dec.

INTRODUCTION: Albuminuria is a clinical hallmark of diabetic nephropathy (DN). Nevertheless, it is controversial whether pathologic DN lesions exist in individuals with diabetes with normoalbuminuria. We investigated the association between albuminuria levels and the frequency of DN lesions in...

Cite
Sasaki T, Nakagawa K, Hata J, et al. Pathologic Diabetic Nephropathy in Autopsied Diabetic Cases With Normoalbuminuria From a Japanese Community-Based Study. Kidney Int Rep. 2021;6(12):3035-3044doi: 10.1016/j.ekir.2021.09.007.
Sasaki, T., Nakagawa, K., Hata, J., Hirakawa, Y., Shibata, M., Nakano, T., Tsuboi, N., Oda, Y., Kitazono, T., Yokoo, T., & Ninomiya, T. (2021). Pathologic Diabetic Nephropathy in Autopsied Diabetic Cases With Normoalbuminuria From a Japanese Community-Based Study. Kidney international reports, 6(12), 3035-3044. https://doi.org/10.1016/j.ekir.2021.09.007
Sasaki, Takaya, et al. "Pathologic Diabetic Nephropathy in Autopsied Diabetic Cases With Normoalbuminuria From a Japanese Community-Based Study." Kidney international reports vol. 6,12 (2021): 3035-3044. doi: https://doi.org/10.1016/j.ekir.2021.09.007
Sasaki T, Nakagawa K, Hata J, Hirakawa Y, Shibata M, Nakano T, Tsuboi N, Oda Y, Kitazono T, Yokoo T, Ninomiya T. Pathologic Diabetic Nephropathy in Autopsied Diabetic Cases With Normoalbuminuria From a Japanese Community-Based Study. Kidney Int Rep. 2021 Sep 22;6(12):3035-3044. doi: 10.1016/j.ekir.2021.09.007. eCollection 2021 Dec. PMID: 34901572; PMCID: PMC8640559.
Copy Download .nbib Format: NLM
KANPHOS: A Database of Kinase-Associated Neural Protein Phosphorylation in the Brain.

Cells

Ahammad RU, Nishioka T, Yoshimoto J, Kannon T, Amano M, Funahashi Y, Tsuboi D, Faruk MO, Yamahashi Y, Yamada K, Nagai T, Kaibuchi K.
PMID: 35011609
Cells. 2021 Dec 24;11(1). doi: 10.3390/cells11010047.

Protein phosphorylation plays critical roles in a variety of intracellular signaling pathways and physiological functions that are controlled by neurotransmitters and neuromodulators in the brain. Dysregulation of these signaling pathways has been implicated in neurodevelopmental disorders, including autism spectrum...

Cite
Ahammad RU, Nishioka T, Yoshimoto J, et al. KANPHOS: A Database of Kinase-Associated Neural Protein Phosphorylation in the Brain. Cells. 2021;11(1)doi: 10.3390/cells11010047.
Ahammad, R. U., Nishioka, T., Yoshimoto, J., Kannon, T., Amano, M., Funahashi, Y., Tsuboi, D., Faruk, M. O., Yamahashi, Y., Yamada, K., Nagai, T., & Kaibuchi, K. (2021). KANPHOS: A Database of Kinase-Associated Neural Protein Phosphorylation in the Brain. Cells, 11(1), . https://doi.org/10.3390/cells11010047
Ahammad, Rijwan Uddin, et al. "KANPHOS: A Database of Kinase-Associated Neural Protein Phosphorylation in the Brain." Cells vol. 11,1 (2021). doi: https://doi.org/10.3390/cells11010047
Ahammad RU, Nishioka T, Yoshimoto J, Kannon T, Amano M, Funahashi Y, Tsuboi D, Faruk MO, Yamahashi Y, Yamada K, Nagai T, Kaibuchi K. KANPHOS: A Database of Kinase-Associated Neural Protein Phosphorylation in the Brain. Cells. 2021 Dec 24;11(1). doi: 10.3390/cells11010047. PMID: 35011609; PMCID: PMC8750479.
Copy Download .nbib Format: NLM
Efficacy of His Bundle Pacing on LV Relaxation and Clinical Improvement in Heart Failure and LBBB.

JACC. Clinical electrophysiology

Kato H, Yanagisawa S, Sakurai T, Mizuno C, Ota R, Watanabe R, Suga K, Okada T, Murakami H, Kada K, Inden Y, Tsuboi N, Murohara T.
PMID: 34454880
JACC Clin Electrophysiol. 2021 Aug 17; doi: 10.1016/j.jacep.2021.06.011. Epub 2021 Aug 17.

OBJECTIVES: This study aimed to compare acute hemodynamic improvements and responses to His bundle pacing (HBP) and conventional biventricular pacing (BVP).BACKGROUND: HBP can correct left bundle branch block (LBBB) and may be an alternative cardiac resynchronization therapy (CRT) to...

Cite
Kato H, Yanagisawa S, Sakurai T, et al. Efficacy of His Bundle Pacing on LV Relaxation and Clinical Improvement in Heart Failure and LBBB. JACC Clin Electrophysiol. 2021;doi: 10.1016/j.jacep.2021.06.011.
Kato, H., Yanagisawa, S., Sakurai, T., Mizuno, C., Ota, R., Watanabe, R., Suga, K., Okada, T., Murakami, H., Kada, K., Inden, Y., Tsuboi, N., & Murohara, T. (2021). Efficacy of His Bundle Pacing on LV Relaxation and Clinical Improvement in Heart Failure and LBBB. JACC. Clinical electrophysiology, . https://doi.org/10.1016/j.jacep.2021.06.011
Kato, Hiroyuki, et al. "Efficacy of His Bundle Pacing on LV Relaxation and Clinical Improvement in Heart Failure and LBBB." JACC. Clinical electrophysiology vol. (2021). doi: https://doi.org/10.1016/j.jacep.2021.06.011
Kato H, Yanagisawa S, Sakurai T, Mizuno C, Ota R, Watanabe R, Suga K, Okada T, Murakami H, Kada K, Inden Y, Tsuboi N, Murohara T. Efficacy of His Bundle Pacing on LV Relaxation and Clinical Improvement in Heart Failure and LBBB. JACC Clin Electrophysiol. 2021 Aug 17; doi: 10.1016/j.jacep.2021.06.011. Epub 2021 Aug 17. PMID: 34454880.
Copy Download .nbib Format: NLM
Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey.

Asian journal of psychiatry

Shinozaki M, Yasui-Furukori N, Adachi N, Ueda H, Hongo S, Azekawa T, Kubota Y, Katsumoto E, Edagawa K, Goto E, Miki K, Kato M, Nakagawa A, Kikuchi T, Tsuboi T, Watanabe K, Shimoda K, Yoshimura R.
PMID: 34844178
Asian J Psychiatr. 2021 Nov 23;67:102935. doi: 10.1016/j.ajp.2021.102935. Epub 2021 Nov 23.

OBJECTIVE: There is limited information available on the prescription of psychotropic agents to patients with bipolar I (BD-I) and bipolar II disorder (BD-II). The purpose of this study was to investigate the characteristics of drug therapy in BD-I and...

Cite
Shinozaki M, Yasui-Furukori N, Adachi N, et al. Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey. Asian J Psychiatr. 2021;67:102935doi: 10.1016/j.ajp.2021.102935.
Shinozaki, M., Yasui-Furukori, N., Adachi, N., Ueda, H., Hongo, S., Azekawa, T., Kubota, Y., Katsumoto, E., Edagawa, K., Goto, E., Miki, K., Kato, M., Nakagawa, A., Kikuchi, T., Tsuboi, T., Watanabe, K., Shimoda, K., & Yoshimura, R. (2021). Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey. Asian journal of psychiatry, 67102935. https://doi.org/10.1016/j.ajp.2021.102935
Shinozaki, Masataka, et al. "Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey." Asian journal of psychiatry vol. 67 (2021): 102935. doi: https://doi.org/10.1016/j.ajp.2021.102935
Shinozaki M, Yasui-Furukori N, Adachi N, Ueda H, Hongo S, Azekawa T, Kubota Y, Katsumoto E, Edagawa K, Goto E, Miki K, Kato M, Nakagawa A, Kikuchi T, Tsuboi T, Watanabe K, Shimoda K, Yoshimura R. Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey. Asian J Psychiatr. 2021 Nov 23;67:102935. doi: 10.1016/j.ajp.2021.102935. Epub 2021 Nov 23. PMID: 34844178.
Copy Download .nbib Format: NLM
Clinically amyopathic dermatomyositis associated with anti-nuclear matrix protein 2 antibody.

Rheumatology advances in practice

Abe S, Tsuboi H, Toko H, Honda F, Yagishita M, Hagiwara S, Kondo Y, Konishi R, Okune M, Ichimura Y, Okiyama N, Matsumoto I.
PMID: 34988361
Rheumatol Adv Pract. 2021 Dec 20;5(3):rkab104. doi: 10.1093/rap/rkab104. eCollection 2021.

No abstract available.

Cite
Abe S, Tsuboi H, Toko H, et al. Clinically amyopathic dermatomyositis associated with anti-nuclear matrix protein 2 antibody. Rheumatol Adv Pract. 2021;5(3):rkab104doi: 10.1093/rap/rkab104.
Abe, S., Tsuboi, H., Toko, H., Honda, F., Yagishita, M., Hagiwara, S., Kondo, Y., Konishi, R., Okune, M., Ichimura, Y., Okiyama, N., & Matsumoto, I. (2021). Clinically amyopathic dermatomyositis associated with anti-nuclear matrix protein 2 antibody. Rheumatology advances in practice, 5(3), rkab104. https://doi.org/10.1093/rap/rkab104
Abe, Saori, et al. "Clinically amyopathic dermatomyositis associated with anti-nuclear matrix protein 2 antibody." Rheumatology advances in practice vol. 5,3 (2021): rkab104. doi: https://doi.org/10.1093/rap/rkab104
Abe S, Tsuboi H, Toko H, Honda F, Yagishita M, Hagiwara S, Kondo Y, Konishi R, Okune M, Ichimura Y, Okiyama N, Matsumoto I. Clinically amyopathic dermatomyositis associated with anti-nuclear matrix protein 2 antibody. Rheumatol Adv Pract. 2021 Dec 20;5(3):rkab104. doi: 10.1093/rap/rkab104. eCollection 2021. PMID: 34988361; PMCID: PMC8710850.
Copy Download .nbib Format: NLM
Personalized Medicine in Parkinson's Disease: New Options for Advanced Treatments.

Journal of personalized medicine

Mishima T, Fujioka S, Morishita T, Inoue T, Tsuboi Y.
PMID: 34357117
J Pers Med. 2021 Jul 10;11(7). doi: 10.3390/jpm11070650.

Parkinson's disease (PD) presents varying motor and non-motor features in each patient owing to their different backgrounds, such as age, gender, genetics, and environmental factors. Furthermore, in the advanced stages, troublesome symptoms vary between patients due to motor and...

Cite
Mishima T, Fujioka S, Morishita T, et al. Personalized Medicine in Parkinson's Disease: New Options for Advanced Treatments. J Pers Med. 2021;11(7)doi: 10.3390/jpm11070650.
Mishima, T., Fujioka, S., Morishita, T., Inoue, T., & Tsuboi, Y. (2021). Personalized Medicine in Parkinson's Disease: New Options for Advanced Treatments. Journal of personalized medicine, 11(7), . https://doi.org/10.3390/jpm11070650
Mishima, Takayasu, et al. "Personalized Medicine in Parkinson's Disease: New Options for Advanced Treatments." Journal of personalized medicine vol. 11,7 (2021). doi: https://doi.org/10.3390/jpm11070650
Mishima T, Fujioka S, Morishita T, Inoue T, Tsuboi Y. Personalized Medicine in Parkinson's Disease: New Options for Advanced Treatments. J Pers Med. 2021 Jul 10;11(7). doi: 10.3390/jpm11070650. PMID: 34357117; PMCID: PMC8303729.
Copy Download .nbib Format: NLM
The prevalence of current smokers and alcohol drinkers among cancer survivors and subjects with no history of cancer among participants in a community-based cardiometabolic screening program in Miyagi prefecture, Japan: a comparison with nationally representative surveys in other countries.

Cancer medicine

Nishimoto Y, Tsubono Y, Kogure M, Nakamura T, Itabashi F, Tsuchiya N, Nakaya N, Tanno K, Sugawara J, Kuriyama S, Kure S, Tsuji I, Hozawa A.
PMID: 34850586
Cancer Med. 2021 Dec;10(24):9000-9011. doi: 10.1002/cam4.4364. Epub 2021 Dec 01.

BACKGROUND: We determined the prevalence of current cigarette smokers and alcohol drinkers among cancer survivors and subjects with no history of cancer in Japan and compared the findings with nationally representative studies in other countries.METHODS: We conducted a cross-sectional...

Cite
Nishimoto Y, Tsubono Y, Kogure M, et al. The prevalence of current smokers and alcohol drinkers among cancer survivors and subjects with no history of cancer among participants in a community-based cardiometabolic screening program in Miyagi prefecture, Japan: a comparison with nationally representative surveys in other countries. Cancer Med. 2021;10(24):9000-9011doi: 10.1002/cam4.4364.
Nishimoto, Y., Tsubono, Y., Kogure, M., Nakamura, T., Itabashi, F., Tsuchiya, N., Nakaya, N., Tanno, K., Sugawara, J., Kuriyama, S., Kure, S., Tsuji, I., & Hozawa, A. (2021). The prevalence of current smokers and alcohol drinkers among cancer survivors and subjects with no history of cancer among participants in a community-based cardiometabolic screening program in Miyagi prefecture, Japan: a comparison with nationally representative surveys in other countries. Cancer medicine, 10(24), 9000-9011. https://doi.org/10.1002/cam4.4364
Nishimoto, Yuka, et al. "The prevalence of current smokers and alcohol drinkers among cancer survivors and subjects with no history of cancer among participants in a community-based cardiometabolic screening program in Miyagi prefecture, Japan: a comparison with nationally representative surveys in other countries." Cancer medicine vol. 10,24 (2021): 9000-9011. doi: https://doi.org/10.1002/cam4.4364
Nishimoto Y, Tsubono Y, Kogure M, Nakamura T, Itabashi F, Tsuchiya N, Nakaya N, Tanno K, Sugawara J, Kuriyama S, Kure S, Tsuji I, Hozawa A. The prevalence of current smokers and alcohol drinkers among cancer survivors and subjects with no history of cancer among participants in a community-based cardiometabolic screening program in Miyagi prefecture, Japan: a comparison with nationally representative surveys in other countries. Cancer Med. 2021 Dec;10(24):9000-9011. doi: 10.1002/cam4.4364. Epub 2021 Dec 01. PMID: 34850586.
Copy Download .nbib Format: NLM
Showing 913 to 924 of 937 entries